SARAH KOZAR: Open Payments
NPI 1770112120 · OKEMOS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,964 in 125 payments from 16 companies in 2025. Trend: 2023 $1,890 · 2024 $1,388 · 2025 $1,964
Food & beverage: $1,964
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 17 | $265 |
| GENZYME CORPORATION | 10 | $242 |
| Amgen Inc. | 11 | $240 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 16 | $184 |
| Galderma Laboratories, L.P. | 19 | $169 |
| Janssen Biotech, Inc. | 19 | $157 |
| ABBVIE INC. | 6 | $124 |
| Incyte Corporation | 4 | $102 |
| UCB, Inc. | 4 | $95 |
| Regeneron Healthcare Solutions, Inc. | 3 | $82 |
Products named: DUPIXENT, OTEZLA, VTAMA, TREMFYA, NEMLUVIO, Winlevi, OPZELURA, SKYRIZI.
Industry payments across MI — which companies pay providers there.
